Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Jörg Reinhardt to leave Bayer for Novartis

January 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Novartis, Reinhardt

The chairman of the Board and member of the Bayer executive council Dr Jörg Reinhard is stepping down from his …
Appointment
Watson image

Watson buys women’s health specialists

January 23, 2013 Research and Development, Sales and Marketing Actavis, Uteron, Watson, women

Watson has completed the acquisition of Uteron Pharma, a Belgium R&D-based firm specialising in women’s health products. The world’s third-largest …
News
novartis image

EU approval for meningitis vaccine

January 23, 2013 Sales and Marketing Bexsero, CHMP, Novartis, meningitis

European regulators have approved Novartis’ Bexsero, making it the first broad coverage vaccine to target the leading cause of meningitis. …
News

New drug discovery alliance launches

January 23, 2013 Research and Development, Sales and Marketing CDRD, LDC, translational research

Six of the world’s top health science centres have banded together in an attempt to speed up the rate at …
News
john_reed

Roche adds head to corporate executive committee

January 23, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Reed, Roche

Roche has announced that John Reed has been appointed as head of Roche Pharma Research and Early Development (pRED) and …
Appointment
Allergan image

Botox US bladder indication

January 22, 2013 Sales and Marketing Allergan, Botox, FDA, bladder

Allergan’s Botox has been given approval by the FDA for the treatment of overactive bladder (OAB) in adults.Botox (onabotulinumtoxinA) has …
News

Lundbeck sells $100m portfolio

January 22, 2013 Sales and Marketing Lundbeck, OTC, Panhematin, Recordati

Italian pharma group Recordati has paid $80 million to Lundbeck for a portfolio of products primarily aimed at the US …
News
karl_hamer

New appointment and promotions at Events 4 Healthcare

January 22, 2013 Medical Communications, Sales and Marketing Events 4 Healthcare

Comms agency Events 4 Healthcare has announced two new promotions and a new appointment to further enhance its team. Nicola …
Appointment
Novartis image

Novartis eye drug nears approval

January 21, 2013 Sales and Marketing AMD, CHMP, Jetria, Novartis

Novartis’ eye drug Jetrea has been given a positive opinion by the CHMP, pushing it to the brink of approval. …
News

CHMP nod for Pfizer CML drug

January 21, 2013 Sales and Marketing CHMP, CML, FDA, Pfizer

Pfizer’s cancer drug bosutinib has been given a positive opinion by the CHMP for patients with chronic myelogenous leukemia (CML). …
News

Crohn’s and Colitis UK hire new chief executive

January 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Crohn's and Colitis, David Barker

The medical charity Crohn’s and Colitis UK Trustees have announced the appointment of David Barker as the new chief executive …
Appointment
Lilly image

EU nod for Lilly brain diagnostic

January 18, 2013 Research and Development, Sales and Marketing Alzhheimer's, Amyvid, brain, lilly

Eli Lilly’s diagnostic radiopharmaceutical Amyvid has been approved in Europe to assess whether patients have Alzheimer’s disease. Amyvid (Florbetapir F …
News
ec-burgess_1000px

Roche’s Burgess to head up discovery at BMS

January 18, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Burgess

Bristol-Myers Squibb has appointed Mike Burgess as senior vice president, Discovery Medicine and Clinical Pharmacology. He will report to Francis …
Appointment
Tysabri image

Biogen and Elan file for Tysabri first line use in MS

January 18, 2013 Sales and Marketing Biogen IDEC, EMA, Elan, FDA, MS, Tsyabri, gilenya

Biogen Idec and Elan have applied to the FDA and EMA to expand Tysabri’s use in patients with relapsing forms …
News

MPs: ‘get on with VBP’

January 18, 2013 Medical Communications, Sales and Marketing NHS, NICE, PPRS, VBP

An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …
News
The Gateway to Local Adoption Series

Latest content

Femtosecond laser cuts lung tumour margin assessment time

October 15, 2026

Blood sensor detects Parkinson’s-associated proteins in 40 minutes

October 15, 2026

Cori Clinical raises US$4m to expand AI platform for clinical trial design

October 14, 2026

Ofichem acquires US drug substance CDMO Kinentia

October 14, 2026

Jager-van Dijk is new Arletta Pharma Solutions CEO 

October 13, 2026